Navigation Links
Experimental Biology 2008 Today's Research: Tomorrow's Health, April 5-9
Date:2/4/2008

More than 13,000 biological and biomedical scientists will gather for the Experimental Biology 2008 meeting in San Diego April 5-9.

The theme of the annual meeting, now in its 18th year, is Todays Research: Tomorrows Health. Thousands of lectures, symposia, research presentations and exhibits have been selected because of their potential to shape future and current clinical advances. Scientists and clinicians from dozens of different disciplines, from laboratory to translational to clinical research, from throughout the U.S. and the world, come together at Experimental Biology to discuss the newest scientific concepts and share the latest research findings with colleagues looking at similar biomedical problems through the lens of different disciplines.

The seven sponsoring societies for Experimental Biology 2008 are: American Association of Anatomists (AAA), The American Association of Immunologists (AAI), The American Physiological Society (APS), American Society for Biochemistry and Molecular Biology (ASBMB), American Society for Investigative Pathology (ASIP), American Society for Nutrition (ASN), and American Society for Pharmacology and Experimental Therapeutics (ASPET). Experimental Biology includes the annual meetings of all sponsoring societies.

Forty U.S. and international guest societies further broaden the scope of the meeting, adding scientists from fields such as biomedical engineering, behavioral pharmacology, veterinary pathology and immunology, biological and environmental repositories, and informatics, and from organizations such as the American College of Sports Medicine, American Diabetes Association, and American Heart Association.

The diversity of topics can be seen in this small sampling from the programs of sponsoring societies and their guests (all open to registered media):

Association of American Anatomists presentations range from an award lecture on links between essential self-prese
'/>"/>

Contact: Sylvia Wrobel
ebpress@gmail.com
770-722-1055
Federation of American Societies for Experimental Biology
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
2. Experimental Antidepressants Offer Faster Relief
3. Experimental drug shows promise in advanced kidney cancer
4. Experimental drug boosts survival in recurrent ovarian cancer
5. Experimental cancer pharmaceuticals under trial
6. Experimental Drug Fails Against Heart Failure
7. Experimental Drug Fights Prostate Cancer
8. Experimental technique at GUMC offers real-time analysis of breast cancer biopsies
9. Experimental Vaccine Halts Prostate Cancer in Mice
10. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
11. Carnegie Mellon Establishes Ray and Stephanie Lane Center for Computational Biology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., KELOWNA, BC, Nov. 27 /PRNewswire/ - Uploadabl...eeing prime time in wellness. A combination of adv...ta upload are solving a long term concern over the... to accurately gauge and reward improved participa...logies is one of the first wellness suppliers to i...
(Date:11/27/2009)..., SAN FRANCISCO, Nov. 27 /PRNewswire-FirstCall/...unced that Blair Lambert, CFO/COO, will present at...be held at the May Fair Hotel in London, England, ... ,, To listen to a live broadcast of The Gymbor...lease log on to www.gymboree.com, click on "Our Co...
(Date:11/27/2009)..., KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire-F... SHMR ) ( "Shamir" ), a leading provider of innov...ns market, announced today that its board of direc...gregate amount of US$ 10 million (approximately NI...resentative rate of exchange), or approximately US...
(Date:11/27/2009)...g rates to bring unprecedented medical, economic b...27 (HealthDay News) -- The number of people with d... over the next 25 years, a new study predicts. ,... million people with the disease, up from 23.7 mil...eating people with diabetes will triple, the study...
(Date:11/27/2009)... Multi-purpose bilingual colori...ned for use by the business community to educate -... subjects from Safety issues to Dinosuars to ABC,S... Saint Louis, MO (PRWEB) November 27, 2009 --...ronics or toys to keep them busy any hour of the d...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...ASPS Twins Study Finds Environmental Factors Trump...Ill., Feb. 3 Your mother,s wrinkles -- or lack th...l age. In fact, a new study claims just the opposi...ge. Results just published on the web-based versio...
...CORTLANDT MANOR, N.Y., Feb. 3 Polymedco is please...to colorectal cancer statistics and screening. It...ns to risks, statistics, and screening options for...ay in the United States. However, with proper scr...
... FORT WORTH, Texas, Feb. 3 Galderma Laboratori...ug Administration (FDA) has approved,Vectical(TM) ...product for the,treatment of mild-to-moderate plaq...ed, scaly patches of skin and,caused by an abnorma...
...Event to Benefit The Larry King Cardiac Foundation...th Annual Red Dress Awards will commemorate Americ...iduals who have made significant contributions to ... Jazz at Lincoln Center,s Allen Room. The View ...
... MIAMI, Feb. 3 Baker & McKenzie, and Banks...009 Summit aimed at informing investors,in the hea...February 12th at,the Harvard Club. , Internati...Center of Miami and Palm Beach, Florida,( http://w...
...CHICAGO, Feb. 3 The Female Health Company (NYSE A...n investor conference call to discuss its operatin... a.m. Eastern Time (EST) on Tuesday, February 10, ...cipate in the conference call by dialing 800-860-2...
Other Medicine News:Health News:Divorce, Antidepressants, or Weight Gain/Loss Can Add Years to Your Face 2Health News:Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis 2Health News:Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis 3Health News:Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis 4Health News:Woman's Day Presents the Sixth Annual 'Red Dress Awards' Honoring Women Making Strides in the Fight Against Heart Disease 2Health News:Woman's Day Presents the Sixth Annual 'Red Dress Awards' Honoring Women Making Strides in the Fight Against Heart Disease 3Health News:Woman's Day Presents the Sixth Annual 'Red Dress Awards' Honoring Women Making Strides in the Fight Against Heart Disease 4Health News:Woman's Day Presents the Sixth Annual 'Red Dress Awards' Honoring Women Making Strides in the Fight Against Heart Disease 5Health News:Woman's Day Presents the Sixth Annual 'Red Dress Awards' Honoring Women Making Strides in the Fight Against Heart Disease 6Health News:James G. Schwade, M.D. to Deliver Keynote Address to Financial and Investment Industry in New York 2Health News:The Female Health Company Schedules First Quarter Conference Call for February 10, 2009 2
(Date:11/25/2009)... -- BioTrends Research Group, Inc. released Wave 1...the first in a multi-phase syndicated market resea...Biotech,s Stelara, from product launch through the...he report provides quantitative information from 7...n from a subset of 20. The reports assess trial a...
(Date:11/25/2009)... For many of the millions...million living with untreated hearing loss , the ...st Cindy Beyer. ,, Dr. Beyer, senior vice presi...rgest hearing care and hearing aids companies, s...ustration, and social isolation, "which can easily...
(Date:11/25/2009)...PRNewswire/ -- AMPAC Fine Chemicals LLC (AFC), a s... APFC ) announced today that it received the Envi...at the Annual Statewide Environmental Summit, spon...gy Association (CMTA), the Industrial Environmenta...cil of California (CICC) held in San Diego. This ...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Cruise Ship Virus Vaccine Stems From Tobacco 54758 1Cruise Ship Virus Vaccine Stems From Tobacco 54758 2PetRelocation com and PetMD com Launch Co Branded Pet Travel and Pet Health Resources 54754 1PetRelocation com and PetMD com Launch Co Branded Pet Travel and Pet Health Resources 54754 2PetRelocation com and PetMD com Launch Co Branded Pet Travel and Pet Health Resources 54754 3Bankrupt Medicare to be Burdened With 24Billions More for Translation Costs Says ProEnglish 54750 1
...presented at the 90th annual Endocrine Society mee...ected by moderate to severe vaginal ...Mich, June 16 QuatRx Pharmaceuticals today,announ...al Phase 3 clinical,trial of Ophena(TM) (ospemifen...toms of vulvovaginal atrophy, a common condition a...
...lished in the Journal of the American Society of H...giotensin II reversed vascular ... A new study published in the,current Journal of t...hat,the hypertension treatment olmesartan medoxomi...arteries that occurs in patients with hypertension...
Other Medicine Technology:Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 2Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 3Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 4New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 2New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 3New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 4New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 5New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 6New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 7New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 8New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 9
Long Handle Occluder - White
Long Handle Occluder - Black
49 Pinhole short handle
Red Maddox and Red lens
Medicine Products: